News & Perspective

(CIDRAP News) – A new study suggests that a lab-derived hybrid H5N1 influenza virus that is capable of airborne transmission among ferrets may well be capable of doing the same thing in humans.

(CIDRAP News) – A team of European researchers reported yesterday the discovery of a human monoclonal antibody that binds to all types of influenza A viruses, raising the prospect of a new flu treatment and improving the chances of developing a broadly protective or "universal" flu vaccine.

(CIDRAP News) – Against the backdrop of a global struggle to solve a dispute related to H5N1 avian influenza virus sharing and an anxious watch over the novel H1N1 virus sweeping the globe, a new public database for sharing influenza genetic sequences is easing the flow of data and winning the support of a growing community of researchers and health officials, even some from countries that have sparred in the past over intellectual property rights.

(CIDRAP News) – As the World Health Organization (WHO) convened its annual meeting today, several countries urged the agency to use caution in weighing whether to declare a full-scale pandemic, despite signs that the novel H1N1 influenza virus is now spreading in Japan.

(CIDRAP News) – Indonesia's recent announcement that it would immediately begin sharing H5N1 avian influenza genetic sequences with a new public database is being hailed by experts as a promising development, though there is a concern that having actual virus isolates would be better.

Indonesia's decision, announced by Health Minister Siti Fadilah Supari, was detailed in a May 15 report from the Associated Press (AP).

(CIDRAP News) – Animal health officials in Switzerland today said samples from an asymptomatic duck were positive for H5N1 avian influenza, as officials in India announced a poultry outbreak in another district in West Bengal state.

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.